Related Experiment Video
Updated: Aug 19, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Current pharmacological options in the treatment of croup
Robert Bruce Wright1, Brian H Rowe, Robin J Arent
1Department of Pediatrics, Pediatric Emergency Medicine, 2C3, 8440-112 Street, Edmonton, Alberta, Canada. BWright@cha.ab.ca
Insights
Corticosteroids are the preferred treatment for croup, effectively reducing symptoms and inflammation in children. While nebulized adrenaline helps severe cases, mist therapy and heliox lack proven benefits for croup management.
Area of Science:
- Pediatrics
- Respiratory Medicine
- Pharmacology
Background:
- Croup is a common pediatric respiratory illness causing stridor and distress.
- Effective management aims to reduce symptoms, inflammation, and complications like intubation or hospitalization.
Purpose of the Study:
- To review current evidence on croup treatments.
- To identify optimal therapeutic strategies for symptom relief and improved quality of life.
Main Methods:
- Review of research on therapies for croup.
- Analysis of corticosteroid efficacy via oral, parenteral, and nebulized routes.
- Evaluation of nebulized adrenaline, mist/humidified air, and heliox.
Main Results:
- Corticosteroids are the primary treatment, with oral administration preferred.
- Nebulized adrenaline is effective for severe croup cases.
- Mist/humidified air and heliox lack sufficient evidence for symptom improvement or disease alteration.
Conclusions:
- Corticosteroids are crucial for managing croup symptoms and inflammation.
- Nebulized adrenaline offers a valuable option for severe presentations.
- Further research is needed for heliox, and mist therapy shows no benefit.
Abstract:
Croup is one of the most common respiratory illnesses seen in the acute paediatric setting. It can be a cause of acute stridor and/or respiratory distress in young children. Research has shown that therapy aimed at reducing symptoms and inflammation can reduce complications such as the need for intubation, hospitalisation and improve quality of life for parents and children. Corticosteroids are the primary treatment option that will accomplish both goals and can be used in out-patient and in-patient settings. Corticosteroids may be given orally, parenterally or in wet nebulised form; however, oral administration is the preferred route. Wet nebulised adrenaline (racaemic or l-adrenaline) is also an effective treatment for more severe cases of croup. Recent studies have shown that mist/humidified air provides no additional symptom improvement, nor does it alter the overall cause of the disease process. Currently, there is insufficient randomised controlled trial evidence to support the role of heliox in the short-term treatment of croup.
Related Concept Videos
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Skeletal Muscle Relaxants: Therapeutic Uses
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...